A breakthrough moment in cancer treatment. It is known that a new vaccine has been developed by famous pharmaceutical companies Mark and Moderna. Many times, even after surgery and other methods to remove the cancer, the malignant disease returns. Experts think that this new vaccine can get rid of that danger. It is assumed that people can take this vaccine very soon.
Basically, this vaccine has been tested on patients suffering from skin cancer i.e. melanoma. The vaccine is given experimentally along with the widely used cancer drug Ketruda. The two drug companies have reported positive results after giving the vaccine to patients in the late stage who are at high risk. Initially, it was thought that this vaccine could ensure that once the cancer is removed from the body, it does not come back. The risk of cancer spreading from the skin to other parts of the body will also decrease.
But the peculiarity of this vaccine is that it has to be made individually for each person. This vaccine will be made through mRNA technology. It is known that as a result of this vaccination, a special immune system will be created in the human body. The human body will have the ability to identify and eliminate cancer before it spreads. Moderna and Merck claim that this immune response is enhanced by mixing the vaccine with the drug. In the coming days, they have plans to make this vaccine for skin cancer as well as other parts of the body.
A few days ago, the Russian vaccine manufacturer 'Gamalya Research Institute' also announced that the initial results of their vaccine in the treatment of melanoma are very promising. The patient who received this vaccine is currently healthy and normal. Positive effects are seen in his body. Active substances are being produced in the patient's body, through which the patient can fight against the tumor and its metastasis. It should be noted that last year the Ministry of Health of Russia approved two indigenously developed cancer treatments.